Why These 15 Defensive Stocks Are Surging In 2025

Page 12 of 14

3. ChromaDex Corp (NASDAQ:CDXC)

Number of Hedge Fund Holders In Q4 2024: 15

ChromaDex Corp (NASDAQ:CDXC) makes dietary supplements and ingredients for healthy aging.

The stock is up significantly so far in 2025, as the company reported record-breaking results for the fourth quarter and full year of 2024. Total net sales reached $99.6 million for 2024, up 19% from the previous year.

Fourth-quarter sales alone hit $29.1 million, a 37% increase year-over-year. Tru Niagen, their flagship NAD+ supplement, led this growth with $22.7 million in Q4 sales, up 29%.

Profitability has also improved. ChromaDex posted a net income of $8.6 million for 2024, compared to a smaller profit or loss in prior years. In Q4, net income was $7.2 million. The company ended 2024 with $44.7 million in cash and no debt.

The consensus price target of $9 implies 14.78% upside.

CDXC stock is up 48.35% year-to-date.

Page 12 of 14